Clinical Trial Update: Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating nimotuzumab in combination with sintilimab and chemotherapy for advanced esophageal squamous cell carcinoma and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)
• Sintilimab (sintilimab)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Esophageal Cancer | Phase 2 | Status: RECRUITING